Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts

Aneta Adamiak; Tomasz Rechberger

Abstract

6/2003 vol. 2

Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts

Aneta Adamiak

,

Tomasz Rechberger

(Prz Menopauz 2003, 6: 18–22)

Online publish date: 2003/12/16

View full text

AMA

Adamiak A, Rechberger T. Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts. Menopause Review/Przegląd Menopauzalny. 2003;2(6):18-22.

APA

Adamiak, A., & Rechberger, T. (2003). Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts. Menopause Review/Przegląd Menopauzalny, 2(6), 18-22.

Chicago

Adamiak, Aneta, and Tomasz Rechberger. 2003. "Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts". Menopause Review/Przegląd Menopauzalny 2 (6): 18-22.

Harvard

Adamiak, A., and Rechberger, T. (2003). Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts. Menopause Review/Przegląd Menopauzalny, 2(6), pp.18-22.

MLA

Adamiak, Aneta et al. "Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts." Menopause Review/Przegląd Menopauzalny, vol. 2, no. 6, 2003, pp. 18-22.

Vancouver

Adamiak A, Rechberger T. Hormonal replacement therapy in the treatment of female urinary tract disfunctions – myths and facts. Menopause Review/Przegląd Menopauzalny. 2003;2(6):18-22.

The epidemiological studies reveal that menopause with subsequent hormonal defficiency plays an important role in the etiology of a number of urogenital complaints. In this period the increased occurrence of stress urinary incontinence, overactive bladder and recurrent tract urinary infection is observed. The aim of this paper is to present the actual knowledge about influence of sex steroids on the female lower urinary tract and substantiate the rationale for the hormone replacement therapy in the management of these disorders.